Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple... ( Three-Year Analysis Demonstrates Rob...)

Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis

Date:10/15/2007

Three-Year Analysis Demonstrates Robust, Highly Statistically Significant

Treatment Effect of Alemtuzumab Compared to Rebif(R)

CAMBRIDGE, Mass., Oct. 15 /PRNewswire-FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ) today announced that top-line, three-year data from a completed Phase 2 clinical trial comparing alemtuzumab with Rebif(R) (interferon beta- 1a) for the treatment of multiple sclerosis were presented this weekend at the 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Prague. The results come from an analysis conducted after 36 months of treatment for 334 patients in the three-year trial.

Results of the primary outcomes from this trial were presented by Alastair Compston, professor of neurology and the head of the Department of Clinical Neurosciences at the University of Cambridge, United Kingdom, during the prestigious Charcot Award lecture at ECTRIMS.

Efficacy Results

Overall efficacy results demonstrate that alemtuzumab provides a significant treatment effect that has been found to last three years among patients in the study. Analysis of the first co-primary endpoint showed that patients taking alemtuzumab experienced at least a 73 percent reduction in the risk for relapse after three years of follow up when compared to patients treated with interferon beta-1a. This difference was highly statistically significant in favor of the alemtuzumab patients with a p-value less than the pre-specified value (p=0.00396) assigned for the three-year analysis.

Analysis of the other co-primary endpoint showed that patients taking alemtuzumab experienced at least a 70 percent reduction in the risk for progression of clinically
'/>"/>

SOURCE Genzyme Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
2. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
3. Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line Results with ...
4. Evotec Reports Positive Proof-of-Concept Top-Line Results with Insomnia Drug Candidate EVT 201
5. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
6. Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Companys Investigational Drug to Treat Cocaine and Methamphetamine Addiction
7. Cobalis Expects to Report Phase III Top-Line Results in May
8. XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
9. Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntingtons Disease
10. UCB Announces Positive Top-Line Phase III Results for Keppra as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
11. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin for Multiple Sclerosis

Post Your Comments:

(Date:12/14/2009)... Zargis Medical Corp., a majority-owned subsidiary of Speedus ... from Siemens Corporate Research (NYSE: SI ... its award-winning Zargis Cardioscan(TM) system on Amazon.com, America,s ... Bluetooth®-enabled electronic stethoscope were jointly named Popular ... the Year." Cardioscan is the world,s first ...

(Date:12/14/2009)... 14 Greenway Medical Technologies, Inc. ... Prime Suite (®) 2011, is ... EHR, additionally certified for Child Health and ... Prime Suite 2011 achieved the higher ... offered by the Certification Commission for Health ...

(Date:12/14/2009)... Gibraltar Associates, a leading public ... domestic communications and issues management, today announced ... PositiveID Corporation (Nasdaq: PSID ) to ... of record. Gibraltar Associates will conduct media ... the Company on its public relations programs. ...

Breaking Medicine Technology:Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2 Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 2 Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 3 Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 4 Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation 2 Presidential Towers Donates Apartment to the University of Illinois Medical Center 54638 1 Presidential Towers Donates Apartment to the University of Illinois Medical Center 54638 2 Nonsurgical Technique Can Take Years Off the Appearance of Aging Eyes 54634 1 Nonsurgical Technique Can Take Years Off the Appearance of Aging Eyes 54634 2 Nonsurgical Technique Can Take Years Off the Appearance of Aging Eyes 54634 3 PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry 13593 1 PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry 13593 2 PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry 13593 3 PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry 13593 4

[0] Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com [0] Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification [0] Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation

... 18 Forty-two leading U. S. scientists and specialists gathered at a ... health and national economy from outbreaks of dangerous zoonotic diseases, the FAZD ... innovations: , , , ... Box" on every American kitchen table that detects highly contagious and dangerous ...

... ASPS Study Suggests Nutritional Supplements Prior to ... Identifying,malnutrition before surgery in massive weight ... surgical complications, accelerate,wound healing, improve scar quality ... study in the December issue of Plastic ...

Other Medicine Technology:42 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2 Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2

42 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases Plastic Surgeons Warn of Malnutrition in Body Contouring Patients

(Date:12/14/2009)... Professional HealthCare at Home now provides in-home caregivers who have ... provides home nursing, rehab therapy, caregiver, and hospice services to ... ... Walnut Creek, CA (PRWEB) December 14, 2009 -- Professional ... of total home health care, including nursing, rehab, personal caregiver ...

(Date:12/14/2009)... WASHINGTON, Dec. 14 Following is a ... Tobacco-Free Kids: ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) ,, ... by the National Institute of Drug Abuse shows ... in reducing youth smoking, but declines have slowed ... the decade. In especially troubling news, the ...

(Date:12/14/2009)... of urban teenage girls may acquire at least one ... years of becoming sexually active, according to an Indiana ... , The study appears in the December 2009 issue ... , The researchers followed 381 girls enrolled at ages ... with the organisms that cause chlamydia, gonorrhea and trichomoniasis ...

(Date:12/14/2009)... U.S. Food and Drug Administration (FDA) announced publication ... practices (cGMPs) for the production of positron emission ... document describing acceptable approaches that would enable PET ... proposed regulation. , "We are pleased that ... are so important to the diagnosis and treatment ...

(Date:12/14/2009)... by Novartis Oncology, was conducted independently for CURE magazine among ... facing patients today and better identify their needs. The Leukemia ... the Life Raft Group and GIST Support International react to ... of this release. , ... East ...

[0] Caregivers with Professional HealthCare at Home Now Certified by the Alzheimer's Association [0] New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts [0] IU study: Half of urban teen girls acquire STIs within 2 years of first sexual activity [0] SNM applauds FDA's issuing of new drug manufacturing requirements [0] New Survey Highlights the Challenges of People Living with Rare Cancer

... in 100 11-year-olds had taken a Class A drug, such ... 15-year-olds// have taken hard drugs. There is a rise in ... such as cocaine which has created a lot of trouble ... out among England's 3.4 million secondary pupils. Despite undertaking multi-million-pound ...

... noise, and do not like it much! According to a ... face an increased risk of suffering a heart attack. ... middle-aged adults, living on high-traffic roads and amidst ... suffering heart attack, than those who lived in tranquil surroundings. ...

... though mental disorders are said to account for a ... have been undertaken to assess// this assumption in the ... part of the WHO World Mental Health (WMH) Survey ... adults was done in Lebanon between September, 2002, and ...

... The new low nicotine Quest? cigarettes seems to have ... to a study conducted by researchers// at the Transdisciplinary ... School of Medicine.Results of the study have been published ... ,The author of this study, Caryn Lerman, PhD, Associate ...

... was accused of subjecting patients to unwarranted fertility treatments, ... by the General Medical Council. , ,Professor Craft, ... consistent in his response, of conducting treatments in the ... any of the charges leveled against him. ...

... study conducted by Columbia University Medical Center has ... in osteoarthritis, could be effective// in the treatment ... drug treatment with Cox-2 inhibitors or surgery was ... chronic shoulder pain. ,Approximately 1.5 million ...

Other Medicine News:Health News:A National Survey Revealed That Mental Disorders Are Common In Lebanon 2 Health News:Sodium Hyaluronate Shows Promise In Treatment Of Shoulder Pain 2

Rise in drug use among Pupils Constant Exposure to Noise May Enhance Risk of Heart Attack A National Survey Revealed That Mental Disorders Are Common In Lebanon False Sense Of Security GMC Gives Controversial Fertility Doctor, A Clean Chit Sodium Hyaluronate Shows Promise In Treatment Of Shoulder Pain

Whole blood tube use for microbiology...

BD Vacutainer® Specialty Tubes - Other - Glass...

BD Vacutainer® Specialty Tubes - Lead Testing...

... SST™ Tubes contain spray-coated ... gel for serum separation. ... serum determinations in chemistry. ... efficient means of serum ...

Medicine Products:

BD Vacutainer® Specialty Tubes - Sodium Polyanetholesulfonate (SPS)BD Vacutainer® Specialty Tubes - Other - Glass BD Vacutainer® Specialty Tubes - Lead Testing BD Vacutainer® SST™ Tubes - Plastic

Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple...( Three-Year Analysis Demonstrates Rob...),Health